Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6039)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 25, 2023 (publication date) through Nov 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Chinnadurai R, Wu HHL, Abuomar J, Rengarajan S, New DI, Green D, Kalra PA. Antihypertensive prescribing patterns in non-dialysis dependent chronic kidney disease: Findings from the Salford Kidney Study. World J Nephrol 2023; 12(5): 168-181 [PMID: 38230298 DOI: 10.5527/wjn.v12.i5.168] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Chinnadurai R, Wu HHL, Abuomar J, Rengarajan S, New DI, Green D, Kalra PA. Antihypertensive prescribing patterns in non-dialysis dependent chronic kidney disease: Findings from the Salford Kidney Study. World J Nephrol 2023; 12(5): 168-181 [PMID: 38230298 DOI: 10.5527/wjn.v12.i5.168] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v12/i5/168.htm |
| Number | Citing Articles |
| 1 |
Lianxiang Duan, Ziyang Liu, Ling Chen, Yiqing Yang, Yenan Fan, Jie Chen, Jing Hu, Xuezhong Gong, Yue Guo. Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trial. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1691637
|
| 2 |
Mengxia Cao, Jialing Feng, Xiao Liu, Xiangqiong Wen, Santao Ou. Risk prediction for cardiovascular events and all-cause mortality in maintenance hemodialysis patients. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1660154
|
| 3 |
Hao-Yu Feng, Yi-Qi Wang, Jianhua Yang, Hua Miao, Ying-Yong Zhao, Xiaojuan Li. Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney Disease. Drug Design, Development and Therapy 2025; : 5739 doi: 10.2147/DDDT.S521265
|
| 4 |
KANCHAN SHELKE, TEJAS PARKHE, DHANRAJ SHINDE. OPTIMIZING ANTIHYPERTENSIVE THERAPY IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS: A REVIEW OF DOSE ADJUSTMENTS AND CLINICAL CONSIDERATIONS. International Journal of Pharmacy and Pharmaceutical Sciences 2025; : 25 doi: 10.22159/ijpps.2025v17i8.54827
|
| 5 |
Chen-Hui Jiang, Shui-Juan Zhang, Ping Li, Hua Miao, Ying-Yong Zhao. Natural products targeting TGF-β/Smad signaling in renal fibrosis: multiomics-based novel molecular mechanisms and therapeutic strategies. Phytomedicine 2025; : 157496 doi: 10.1016/j.phymed.2025.157496
|
| 6 |
Jiaying Qiu, Rong Wang, Li Li, Pei Wu, Haibo Zhang, Shengnan Gong, XiaoYan Ren, Yumei Tao, Xingxing Fang. Alternative splicing as a novel pathogenic mechanism in chronic kidney disease. Cellular Signalling 2025; 135: 111972 doi: 10.1016/j.cellsig.2025.111972
|